According to the FDA, 23andMe’s marketing of an unapproved Personal Genome Service (PGS) violated federal law, because, after six years, the firm still had not proved that the tests actually work.
根据FDA的说法，23andMe在推销未经批准的个人基因组服务（PGS），这违反了联邦法，因为该公司花了六年时间还没有证明这些测试实际有用。